Screener
Tango Therapeutics TNGX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
FAQ
- What is Tango Therapeutics's invested capital?
- Tango Therapeutics (TNGX) reported invested capital of $264.33M in Q1 2026.
- How has Tango Therapeutics's invested capital changed year-over-year?
- Tango Therapeutics's invested capital increased by 85.2% year-over-year, from $142.7M to $264.33M.
- What is the long-term trend for Tango Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Tango Therapeutics's invested capital has grown at a 42.7% compound annual growth rate (CAGR), from $45.18M to $267.47M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Tango Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude